A recent study published in JAMA has found that hormone therapy for menopause symptoms is not only safe, but also beneficial for women under the age of 60. Dr. JoAnn Manson, the author of the study, emphasizes that the benefits of hormone therapy outweigh the risks for this demographic.
The study, which is based on data from the Women’s Health Initiative study spanning two decades, highlights the importance of using different types of hormones at lower doses for a safer approach to hormone therapy. Issues with the initial study, such as the use of a problematic progestin and enrolling mostly women over the age of 60, have led to advancements in hormone therapy options.
Micronized progesterone, a bioidentical hormone, has been shown to have fewer side effects and does not increase the risk of breast cancer. Additionally, estrogen therapy through the skin, such as patches or creams, may reduce the risk of blood clots compared to oral estrogen therapy.
Beyond treating hot flashes, hormone therapy also offers benefits such as protection against bone loss and heart disease. Women are encouraged to discuss hormone therapy options with their healthcare providers to determine the best approach for their individual needs.
These findings provide a new perspective on hormone therapy and its potential benefits for women experiencing menopause symptoms. As more research is conducted and new options are considered, hormone therapy continues to be a viable option for managing menopausal symptoms in a safe and effective manner.
“Travel aficionado. Incurable bacon specialist. Tv evangelist. Wannabe internet enthusiast. Typical creator.”